Filters

Acid sphingomyelinase Antibody

Acid sphingomyelinase Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameAcid sphingomyelinase Antibody
Also known asAcid sphingomyelinase Antibody
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenAcid sphingomyelinase
SpecificityThis is a highly specific antibody against Acid sphingomyelinase
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Acid sphingomyelinase
Gene ID number6609
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, Also has phospholipase C activities toward 1, Clinical features are variable, Isoform 2 and isoform 3 have lost catalytic activity, It is an early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide, It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, The severe neurological disorders and pulmonary infections lead to an early death, also known as Niemann-Pick disease classical infantile form, and severe neurologic symptoms, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B, digestive disorders, failure to thrive, leading to cell death, major hepatosplenomegaly, mental retardation, often around the age of four, 2-diacylglycerolphosphocholine and 1, 2-diacylglycerolphosphoglycerol, Converts sphingomyelin to ceramide, Involvement in disease: Defects in SMPD1 are the cause of Niemann-Pick disease type A (NPDA)
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names ASM, ASM_HUMAN, NPD, Smpd1, Sphingomyelin phosphodiesterase, Sphingomyelin phosphodiesterase 1 acid lysosomal, aSMase, Acid sphingomyelinase
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetAcid sphingomyelinase
Short nameAcid sphingomyelinase Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameAcid sphingomyelinase (Antibody to)
Alternative techniqueantibodies
Identity 11120
Gene SMPD1
Long gene name sphingomyelin phosphodiesterase 1
Synonyms gene name acid lysosomal , sphingomyelin phosphodiesterase 1
Synonyms ASM
Synonyms name acid sphingomyelinase
Locus 11p15, 4
Discovery year 1986-01-01
GenBank acession AB209775
Entrez gene record 6609
Pubmed identfication 1711683
RefSeq identity NM_000543
Havana BLAST/BLAT OTTHUMG00000165453

Subscribe to our Newsletter